NCT02576041View on ClinicalTrials.gov

Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or Urticaria

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Allergic RhinitisUrticaria
Interventions
DRUG

Bilastine

Bilastine tablets once a day for 7+3 days

DRUG

Placebo

Placebo tablets once a day during 7+3 days run in period

Trial Locations (1)

Unknown

Azienda Ospedaliero-Universitaria Policlinico, Modena

All Listed Sponsors
lead

Menarini International Operations Luxembourg SA

INDUSTRY

NCT02576041 - Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or Urticaria | Biotech Hunter | Biotech Hunter